Protalix BioTherapeutics, Inc., Issuer AND Trustee INDENTURE Dated as of _____ ___, 202_ CROSS-REFERENCE TABLE*Protalix BioTherapeutics, Inc. • April 20th, 2022 • Biological products, (no disgnostic substances) • New York
*This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.
